Dupixent (dupilumab) receives positive recommendation from INESSS for the treatment of moderate to severe atopic dermatitis in adolescents

14 July 2020 - The Institut national d'excellence en santé et en services sociaux (INESSS) recommends extending existing coverage in Quebec ...

Read more →

PMPRB changes within scope of Patent Act, rules federal court in judicial review

 13 July 2020 - The Federal Court has upheld reforms to the Patented Medicines Pricing Review Board that updated the ...

Read more →

Canadians demand access to ‘miracle’ cystic fibrosis drug already approved in U.S. and U.K

6 July 2020 - Montreal’s Chelsea Gagnon may look like a healthy 31-year-old woman at first glance, but every single ...

Read more →

Clock ticking on Edmonton family's hope for $2.8 million drug treatment for toddler son

 3 July 2020 - Family hoping Alberta Health will pay for new drug that must be administered by mid-July. ...

Read more →

Canada federal court dismisses drug makers' plea challenging drug price rules

30 June 2020 - The federal court of Canada on Monday dismissed a plea by drug makers challenging the Canadian ...

Read more →

IMC responds to Federal Court decision regarding PMPRB regulatory changes

29 June 2020 - Innovative Medicines Canada released the following statement today in response to the Federal Court of Canada’s ...

Read more →

Consultation on CADTH’s drug reimbursement review procedures

25 June 2020 - CADTH is inviting stakeholder feedback on a revised procedure for its drug reimbursement review processes (i.e., pan-Canadian ...

Read more →

Sandoz Canada launches the biosimilars generation

25 June 2020 - Campaign provides needed, fact-based, information for patients, healthcare providers and Canadians about biosimilar medicines in Canada. ...

Read more →

PMPRB publishes new draft guidelines, launches 30 day consultation

22 June 2020 - As reported earlier this month, the Patented Medicine Prices Review Board has published a new draft ...

Read more →

This drug can treat 90 per cent of cystic fibrosis patients, but it's not available in Canada

19 June 2020 - Struggling to breathe is one of the main symptoms of the novel coronavirus that has recently ...

Read more →

Vertex and Canada hold talks over cystic fibrosis drug, but a deal for newer medicine remains out of reach

18 June 2020 - The icy relationship between Vertex Pharmaceuticals and the Canadian government is showing signs of thawing a ...

Read more →

Rising costs explain why Canada is switching to biosimilars

15 June 2020 - Following in the footsteps of British Columbia, other Canadian provinces are working to implement their own biosimilars ...

Read more →

30 day limit on prescription refills lifted in most provinces

12 June 2020 - Most Canadian provinces have now eased their restrictions on the supply of prescription drugs. ...

Read more →

CADTH publishes final recommendation for Crysvita

1 June 2020 - CADTH has completed its assessment of burosumab for the treatment of patients with X-linked hypophosphatemia. ...

Read more →

Local mother, daughter 'getting loud' for cystic fibrosis and the need for lifesaving medication

31 May 2020 - Beth and Madi Vanstone have been working tirelessly to help other cystic fibrosis patients and other Canadians ...

Read more →